ISL
FRTX

Ingalls & Snyder LLC’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Ingalls & Snyder LLC’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4
Closed -$14K – 391
2014
Q1 		$14K Sell
4
-54
-93% -$189K ﹤0.01% 368
2013
Q4 		$216K Sell
58
-10
-15% -$37.2K 0.01% 321
2013
Q3 		$269K Sell
68
-53
-44% -$210K 0.02% 290
2013
Q2 		$1.2M Buy
+121
New +$1.2M 0.08% 164